Advanced basal cell carcinoma is a form of skin cancer that has grown deeply into surrounding tissues, returned after treatment, or spread to other parts of the body. Although this cancer rarely spreads to distant organs, advanced cases can be difficult to manage because of their location, size.
Basal cell carcinoma is the most common type of skin cancer and develops from basal cells in the skin's outer layer. Advanced basal cell carcinoma may involve extensive local tissue damage, recurrence after previous treatment, or, rarely, spread to distant areas. Early diagnosis and appropriate treatment can help control the disease and reduce further complications. When the cancer becomes difficult to remove surgically or cannot be treated effectively with standard local methods, specialists may consider additional approaches based on the patient's condition and treatment history.
Treatment selection depends on the tumour's size, depth, location, and extent of tissue involvement. A multidisciplinary team may include dermatologists, surgeons, radiation oncologists, and medical oncologists. The team evaluates the potential benefits and risks of each approach before developing an individual treatment plan.
Common treatment options include:
Surgery: Surgical removal may be considered when the tumour can be removed safely. Mohs micrographic surgery examines tissue margins during the procedure and may be useful for selected tumours, particularly in areas where preserving healthy tissue is important.
Radiation therapy: Radiation uses high-energy rays to destroy cancer cells. It may be considered when surgery is unsuitable, when additional local treatment is needed, or when the tumour's location makes an operation difficult.
Targeted therapy: Hedgehog pathway inhibitors, including vismodegib and sonidegib, block molecular signals that contribute to basal cell carcinoma growth. These medicines may be used for selected locally advanced or metastatic cases.
Immunotherapy: Cemiplimab, a PD-1 immune checkpoint inhibitor, may be an option for certain patients whose advanced basal cell carcinoma has progressed during or after Hedgehog pathway inhibitor treatment, or when such treatment is unsuitable.
Each treatment has potential benefits, limitations, and side effects. The choice depends on the patient's circumstances and the specialist's assessment.
Advanced basal cell carcinoma requires careful evaluation because tumours can affect surrounding skin, cartilage, nerves, bones, or other structures. Some cases may involve repeated growth in the same area, while metastatic disease may require treatment directed at cancer cells beyond the original tumour site. Doctors may use a physical examination, biopsy results, imaging studies, and previous medical records to determine the extent of disease.
Important considerations include:
Tumour location and extent: Lesions near the eyes, nose, ears, or other sensitive structures may require specialised treatment planning to preserve function.
Previous treatments: Recurrence or progression after earlier treatment can influence whether targeted therapy, immunotherapy, radiation, or further surgery is considered.
Possible side effects: Hedgehog pathway inhibitors may cause muscle spasms, changes in taste, hair loss, fatigue, and weight loss. Immunotherapy can cause immune-related inflammation affecting organs such as the lungs, liver, intestines, or thyroid. Radiation and surgery have their own potential complications.
General health and preferences: Existing health conditions, treatment tolerance, daily activities, and personal preferences contribute to shared decision-making.
Regular follow-up: Medical appointments help assess treatment response, identify recurrence, manage side effects, and detect new skin cancers. Patients may also be advised to practise sun protection and report suspicious skin changes.
Follow-up schedules vary according to disease severity and treatment type. Patients receiving systemic medicines may need blood tests, symptom assessments, and other monitoring recommended by their healthcare team.
Advanced basal cell carcinoma can often be managed using different treatment approaches, depending on how far the disease has progressed and which treatments are appropriate. A dermatologist or oncology specialist can explain the expected benefits, risks, and alternatives for an individual case. Regular monitoring and timely reporting of new symptoms remain important parts of ongoing care. This information is educational and does not replace personalised medical advice.